Actos Bladder Cancer Settlement Could Cost Takeda $2.7 Billion

Actos Bladder Cancer Settlement Could Cost Takeda $2.7 Billion

Washington, DC: In what has been described as perhaps the largest settlement for a pharmaceutical drug that actively remains on the market, Takeda Pharmaceuticals of Japan will set aside as much as $2.4 billion to settle upwards of 9,000 pending

10
Like
Save

Comments

Comments are disabled for this post.